Oncotarget

Research Papers:

The transcriptomic response to irinotecan in colon carcinoma bearing mice preconditioned by fasting

Franny Jongbloed, Sander A. Huisman, Harry van Steeg, Jeroen L.A. Pennings, Jan N.M. IJzermans, Martijn E.T. Dollé and Ron W.F. de Bruin _

PDF  |  Full Text  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2019; 10:2224-2234. https://doi.org/10.18632/oncotarget.26776

Metrics: PDF 504 views  |   Full Text 824 views  |   ?  


Abstract

Franny Jongbloed1,2, Sander A. Huisman1, Harry van Steeg2,3, Jeroen L.A. Pennings2, Jan N.M. IJzermans1, Martijn E.T. Dollé2 and Ron W.F. de Bruin1

1Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands

2Laboratory for Health Protection Research, National Institute of Public Health and The Environment, Bilthoven, The Netherlands

3Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

Correspondence to:

Ron W.F. de Bruin, email: r.w.f.debruin@erasmusmc.nl

Keywords: fasting; colorectal carcinoma; irinotecan; transcriptome analysis; stress resistance

Received: January 30, 2018     Accepted: February 22, 2019     Published: March 15, 2019

ABSTRACT

Background: Irinotecan use is limited due to severe toxicity. Preconditioning by fasting (PBF) protects against side effects of irinotecan while preserving its antitumor activity. The mechanisms underlying the effects of PBF still need to be elucidated. Here, we investigated the transcriptional responses of PBF on irinotecan in both tumor and healthy liver tissue.

Experimental approach: Male BALB/c mice were subcutaneously injected with C26 colon carcinoma cells. Twelve days after tumor inoculation, two groups were fasted for three days and two groups were allowed food ad libitum (AL). Subsequently, both groups received one dose of irinotecan. Twelve hours after administration mice were sacrificed and blood, tumor and liver tissue were harvested. Blood samples were analyzed to determine liver, kidney and bone marrow function, tissues were used for transcriptome analyses.

Key results: The AL irinotecan group showed worsened organ function and decreased leukocyte numbers. These effects were abated in PBF animals. PBF led to an altered transcriptional response in the liver of irinotecan-treated mice, including decreased cellular injury and increased stress resistance. Hepatic metabolism of irinotecan was also significantly changed due to PBF. The transcriptional response of tumor tissue observed after PBF was hardly affected compared to AL fed animals.

Conclusions: Transcriptional changes after PBF to irinotecan treatment showed an improved protective stress response in healthy liver but not in tumor tissue, including changes in irinotecan metabolism. These data help to unravel the mechanisms underlying the effects of fasting on irinotecan and help to improve outcome of chemotherapeutic treatment in cancer patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26776